Cancer Research Technology Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
33
- Investments
-
77
- Portfolio
-
36
- Exits
-
34
Cancer Research Technology General Information
Company Description
Founded in 1982, Cancer Research Horizons is a venture capital firm based in London, United Kingdom. The firm seeks to invest in companies operating in the therapeutics, diagnostics, medtech, drug discovery, vaccines, artificial intelligence, medical devices, software, and healthcare sectors across the United Kingdom.
Business Details
Website
www.cancerresearchhorizons.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 2 Redman Place
- London E20 1JQ
- England, United Kingdom
Cancer Research Technology Investments (77)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Alethio Therapeutics | 05-Nov-2026 | Later Stage VC | Drug Discovery | Clinical Trials - General | ||
| 52North | 29-Sep-2026 | Diagnostic Equipment | Generating Revenue | |||
| Laigo Bio | 20-Mar-2026 | Drug Discovery | Generating Revenue | |||
| ALTx Therapeutics | 05-Feb-2026 | Drug Discovery | Startup | |||
| Infinitopes | 30-Jan-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Verinnogen | 22-Dec-2025 | Discovery Tools (Healthcare) | Pre-Clinical Trials | |||
| Trogenix | 06-Oct-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Alceus Bio | 01-Jul-2025 | Drug Discovery | Startup | |||
| AiM Medical Robotics | 04-Jun-2025 | Later Stage VC | Surgical Devices | Generating Revenue | ||
| Béa Fertility | 16-May-2025 | Later Stage VC | Therapeutic Devices | Generating Revenue |
Cancer Research Technology Exits (34)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Myricx Bio | 28-Aug-2026 | Merger/Acquisition | |
| Súil Vision | 23-Apr-2026 | ||
| SynPixels | 24-Dec-2025 | ||
| Oxomics | 23-Sep-2025 | ||
| Stroma Biosciences | 25-Feb-2025 | ||
| Chroma Therapeutics | 02-Jul-2024 | ||
| Metabomed | 08-Feb-2024 | ||
| Arquer Diagnostics | 02-Jan-2024 | ||
| Karus Therapeutics | 18-Dec-2023 | Bankruptcy: Liquidation | |
| Macrophage Pharma | 05-Dec-2023 | Bankruptcy: Liquidation |
Cancer Research Technology Investments by Industry, Year, and Region
Cancer Research Technology Co-Investors (95)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Meltwind Advisory | 3 |
|
|
||
| Wilbe Capital |
|
|
|||
| Cambridge Angels |
|
|
|||
| Lilly USA |
|
|
|||
| Sofinnova Partners |
|
|
Cancer Research Technology Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cancer Research Ventures | London, United Kingdom | 1998 |
Cancer Research Technology FAQs
-
What is Cancer Research Technology?
Founded in 1982, Cancer Research Horizons is a venture capital firm based in London, United Kingdom.
-
When was Cancer Research Technology founded?
Cancer Research Technology was founded in 1982.
-
Where is Cancer Research Technology headquartered?
Cancer Research Technology is headquartered in London, United Kingdom.
-
What is Cancer Research Technology's total asset value?
Cancer Research Technology has around in total assets under management.
-
How many investments has Cancer Research Technology made?
Cancer Research Technology has made 77 investments.
-
What has Cancer Research Technology invested in?
Cancer Research Technology has made numerous investments in companies like Alethio Therapeutics, 52North, and Laigo Bio within the Drug Discovery and Diagnostic Equipment industries.
-
What has Cancer Research Technology invested in recently?
Cancer Research Technology's latest investment was on 05-Nov-2026 in Alethio Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process